Aı̈cha Daher

1.1k total citations
24 papers, 838 citations indexed

About

Aı̈cha Daher is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Virology. According to data from OpenAlex, Aı̈cha Daher has authored 24 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 7 papers in Virology. Recurrent topics in Aı̈cha Daher's work include RNA regulation and disease (14 papers), RNA Research and Splicing (14 papers) and RNA Interference and Gene Delivery (10 papers). Aı̈cha Daher is often cited by papers focused on RNA regulation and disease (14 papers), RNA Research and Splicing (14 papers) and RNA Interference and Gene Delivery (10 papers). Aı̈cha Daher collaborates with scholars based in Canada, France and United States. Aı̈cha Daher's co-authors include Anne Gatignol, Éliane Meurs, Guerline Clerzius, Carlos E Melendez-Peña, Sylvie Bannwarth, Sylvanne Daniels, Jean‐François Gélinas, Damian F. J. Purcell, Robert J. Scarborough and Marion Bonnet and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Molecular and Cellular Biology.

In The Last Decade

Aı̈cha Daher

24 papers receiving 820 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aı̈cha Daher Canada 14 675 224 131 128 124 24 838
Guerline Clerzius Canada 7 436 0.6× 160 0.7× 100 0.8× 61 0.5× 126 1.0× 7 541
Siqi Hu China 13 412 0.6× 238 1.1× 69 0.5× 73 0.6× 57 0.5× 38 653
Jean-François Clément Canada 11 414 0.6× 331 1.5× 137 1.0× 154 1.2× 65 0.5× 14 742
Shobha Gunnery United States 10 482 0.7× 133 0.6× 49 0.4× 44 0.3× 67 0.5× 14 571
Alex Harwig Netherlands 16 578 0.9× 123 0.5× 282 2.2× 135 1.1× 50 0.4× 28 762
Sohrab Khan United States 12 348 0.5× 117 0.5× 229 1.7× 143 1.1× 28 0.2× 18 587
Michèle Brocard United Kingdom 11 450 0.7× 51 0.2× 31 0.2× 110 0.9× 63 0.5× 13 559
Mukesh Kumar Lalwani India 10 633 0.9× 76 0.3× 106 0.8× 567 4.4× 28 0.2× 13 816
Paulina S. Rubilar France 8 378 0.6× 63 0.3× 77 0.6× 59 0.5× 55 0.4× 9 446
Hannah M. Burgess United States 11 416 0.6× 71 0.3× 29 0.2× 63 0.5× 78 0.6× 17 533

Countries citing papers authored by Aı̈cha Daher

Since Specialization
Citations

This map shows the geographic impact of Aı̈cha Daher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aı̈cha Daher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aı̈cha Daher more than expected).

Fields of papers citing papers by Aı̈cha Daher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aı̈cha Daher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aı̈cha Daher. The network helps show where Aı̈cha Daher may publish in the future.

Co-authorship network of co-authors of Aı̈cha Daher

This figure shows the co-authorship network connecting the top 25 collaborators of Aı̈cha Daher. A scholar is included among the top collaborators of Aı̈cha Daher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aı̈cha Daher. Aı̈cha Daher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Corpo, Olivier Del, et al.. (2020). Efficacy, accumulation, and transcriptional profile of anti-HIV shRNAs expressed from human U6, 7SK, and H1 promoters. Molecular Therapy — Nucleic Acids. 23. 1020–1034. 9 indexed citations
2.
Corpo, Olivier Del, et al.. (2019). A U1i RNA that Enhances HIV-1 RNA Splicing with an Elongated Recognition Domain Is an Optimal Candidate for Combination HIV-1 Gene Therapy. Molecular Therapy — Nucleic Acids. 18. 815–830. 10 indexed citations
3.
Daher, Aı̈cha, et al.. (2018). ADAR1 and PKR, interferon stimulated genes with clashing effects on HIV-1 replication. Cytokine & Growth Factor Reviews. 40. 48–58. 30 indexed citations
4.
5.
6.
Scarborough, Robert J., Kelsey Adams, Olivier Del Corpo, Aı̈cha Daher, & Anne Gatignol. (2016). Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy. Journal of Visualized Experiments. 4 indexed citations
7.
Scarborough, Robert J., Kelsey Adams, Olivier Del Corpo, Aı̈cha Daher, & Anne Gatignol. (2016). Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy. Journal of Visualized Experiments. 4 indexed citations
8.
Daniels, Sylvanne, Natalie J Ward, Carlos E Melendez-Peña, et al.. (2015). HIV-1 RRE RNA acts as an RNA silencing suppressor by competing with TRBP-bound siRNAs. RNA Biology. 12(2). 123–135. 11 indexed citations
9.
Scarborough, Robert J., Kelsey Adams, Aı̈cha Daher, & Anne Gatignol. (2015). Effective Inhibition of HIV-1 Production by Short Hairpin RNAs and Small Interfering RNAs Targeting a Highly Conserved Site in HIV-1 Gag RNA Is Optimized by Evaluating Alternative Length Formats. Antimicrobial Agents and Chemotherapy. 59(9). 5297–5305. 11 indexed citations
10.
Daher, Aı̈cha, et al.. (2014). HIV-1 translation and its regulation by cellular factors PKR and PACT. Virus Research. 193. 65–77. 24 indexed citations
11.
Clerzius, Guerline, Eileen Shaw, Aı̈cha Daher, et al.. (2013). The PKR activator, PACT, becomes a PKR inhibitor during HIV-1 replication. Retrovirology. 10(1). 96–96. 55 indexed citations
12.
Daniels, Sylvanne, Carlos E Melendez-Peña, Robert J. Scarborough, et al.. (2009). Characterization of the TRBP domain required for Dicer interaction and function in RNA interference. BMC Molecular Biology. 10(1). 38–38. 108 indexed citations
13.
Clerzius, Guerline, Jean‐François Gélinas, Aı̈cha Daher, et al.. (2009). ADAR1 Interacts with PKR during Human Immunodeficiency Virus Infection of Lymphocytes and Contributes to Viral Replication. Journal of Virology. 83(19). 10119–10128. 115 indexed citations
14.
Daher, Aı̈cha, Madhurima Singh, Carlos E Melendez-Peña, et al.. (2008). TRBP Control of PACT-Induced Phosphorylation of Protein Kinase R Is Reversed by Stress. Molecular and Cellular Biology. 29(1). 254–265. 103 indexed citations
15.
16.
Daher, Aı̈cha, Sylvie Bannwarth, Johannes Voortman, et al.. (2003). Additive Activity between the Trans -Activation Response RNA-Binding Protein, TRBP2, and Cyclin T1 on HIV Type 1 Expression and Viral Production in Murine Cells. AIDS Research and Human Retroviruses. 19(9). 767–778. 15 indexed citations
17.
Daher, Aı̈cha, M. Longuet, Dominique Dorin, et al.. (2001). Two Dimerization Domains in the Trans-activation Response RNA-binding Protein (TRBP) Individually Reverse the Protein Kinase R Inhibition of HIV-1 Long Terminal Repeat Expression. Journal of Biological Chemistry. 276(36). 33899–33905. 86 indexed citations
18.
Duarte, Mariela, Kenneth Graham, Aı̈cha Daher, et al.. (2000). Characterization of TRBP1 and TRBP2. Journal of Biomedical Science. 7(6). 494–506. 23 indexed citations
19.
Duarte, Mariela, Kenneth Graham, Aı̈cha Daher, et al.. (2000). Characterization of TRBP1 and TRBP2. Journal of Biomedical Science. 7(6). 494–506. 30 indexed citations
20.
Daher, Aı̈cha. (1998). Effect of pre-conceptional external or internal irradiation of N5 male mice and the risk of leukemia in their offspring. Carcinogenesis. 19(9). 1553–1558. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guerline Clerzius Breakdown of academic impact, for papers by Siqi Hu Breakdown of academic impact, for papers by Jean-François Clément Breakdown of academic impact, for papers by Shobha Gunnery Breakdown of academic impact, for papers by Alex Harwig Breakdown of academic impact, for papers by Sohrab Khan Breakdown of academic impact, for papers by Michèle Brocard Breakdown of academic impact, for papers by Mukesh Kumar Lalwani Breakdown of academic impact, for papers by Paulina S. Rubilar Breakdown of academic impact, for papers by Hannah M. Burgess
Rankless by CCL
2026